HSV shedding
- PMID: 15450382
- DOI: 10.1016/j.antiviral.2004.06.004
HSV shedding
Abstract
Viral shedding of HSV occurs frequently in infected individuals. HSV is shed asymptomatically from multiple anatomical sites and shedding, like exposure, is a significant risk for transmission. However, the relationship between shedding frequency, viral titer and transmission is unknown. HSV-2 shedding is affected by the site and time since acquisition of infection. The advent of sensitive PCR techniques has shown that the magnitude and frequency of viral shedding is higher than shown previously with viral culture techniques. It has also clearly demonstrated that suppressive (daily) antiviral therapy reduces clinical and subclinical reactivation rates, and has been successfully used in the prevention of recurrent oral and genital HSV infections. A recent study has demonstrated that daily antiviral therapy with valaciclovir can significantly reduce transmission of HSV-2 between discordant heterosexual couples in monogamous relationships.
Similar articles
-
Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.J Infect Dis. 2004 Oct 15;190(8):1374-81. doi: 10.1086/424519. Epub 2004 Sep 20. J Infect Dis. 2004. PMID: 15378428 Clinical Trial.
-
The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.Sex Transm Dis. 2008 Mar;35(3):286-90. doi: 10.1097/OLQ.0b013e31815b0132. Sex Transm Dis. 2008. PMID: 18157071 Clinical Trial.
-
Prevention of herpes simplex virus type 2 transmission with antiviral therapy.Herpes. 2004 Aug;11 Suppl 3:170A-174A. Herpes. 2004. PMID: 15319087 Review.
-
Reducing the risk of transmitting genital herpes: advances in understanding and therapy.Curr Med Res Opin. 2005 Oct;21(10):1577-82. doi: 10.1185/030079905X61901. Curr Med Res Opin. 2005. PMID: 16238897 Review.
-
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?Antiviral Res. 2004 Aug;63 Suppl 1:S3-9. doi: 10.1016/j.antiviral.2004.06.002. Antiviral Res. 2004. PMID: 15450380 Review.
Cited by
-
The Tail Wagging the Dog (or the Challenges Faced When the Financing of Medicine Gets Ahead of the Science of Medicine).J Clin Microbiol. 2018 Sep 25;56(10):e00904-18. doi: 10.1128/JCM.00904-18. Print 2018 Oct. J Clin Microbiol. 2018. PMID: 30021827 Free PMC article.
-
Viral lower urinary tract infections.Curr Prostate Rep. 2007;5(1):40-50. doi: 10.1007/s11918-007-0006-7. Epub 2007 Apr 16. Curr Prostate Rep. 2007. PMID: 32214913 Free PMC article.
-
Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi.J Vis Exp. 2016 Jul 6;(113):54162. doi: 10.3791/54162. J Vis Exp. 2016. PMID: 27501265 Free PMC article.
-
Herpes Simplex Virus (HSV) Modulation of Staphylococcus aureus and Candida albicans Initiation of HeLa 299 Cell-Associated Biofilm.Curr Microbiol. 2016 May;72(5):529-37. doi: 10.1007/s00284-015-0975-7. Epub 2016 Jan 13. Curr Microbiol. 2016. PMID: 26758707 Free PMC article.
-
A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.PLoS One. 2009 Nov 30;4(11):e8060. doi: 10.1371/journal.pone.0008060. PLoS One. 2009. PMID: 20011586 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical